Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies
Source: BioSpace

Leap Therapeutics: Leap Therapeutics Reports Second Quarter 2020 Financial Results

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the second quarter ended June 30, 2020.

Read full article »
Leap Therapeutics's Competitors | Leap Therapeutics's News | Leap Therapeutics's Financials

January 26, 2021

MarketScreener

Amgen : Alliance for the Million Hearts Campaign Aims to Prevent One Million Heart Attacks and Strokes by 2022

(marketscreener.com) Cardiovascular disease is a leading public health issue. A heart attack strikes ... See more »

January 26, 2021

GlobalNewswire

Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination

LEXINGTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology co... See more »

January 26, 2021

MarketScreener

Amgen : Alliance for the Million Hearts Campaign Aims to Prevent One Million Heart Attacks and Strokes by 2022

(marketscreener.com) Cardiovascular disease is a leading public health issue. A heart attack strikes ... See more »

January 26, 2021

GlobalNewswire

Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination

LEXINGTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology co... See more »
Stay up-to-date with the latest news on Leap Therapeutics

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Chris Mirabelli's photo - CEO of Leap Therapeutics

CEO

Chris Mirabelli

CEO Approval Rating

73/100

Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more

Stay up-to-date with the latest news on Leap Therapeutics